Edgewise Therapeutics, Inc. (EWTX)
32.83
-0.50
(-1.50%)
USD |
NASDAQ |
Apr 06, 16:00
32.86
+0.03
(+0.09%)
After-Hours: 20:00
Edgewise Therapeutics SG&A Expense (TTM) : 40.02M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Glaukos Corp. | 331.75M |
| Nuvalent, Inc. | 107.34M |
| Boston Scientific Corp. | 6.888B |
| Edwards Lifesciences Corp. | 2.085B |
| Eli Lilly & Co. | 11.09B |